Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
24 July 2013Website:
http://www.scorpiusbiologics.comNext earnings report:
14 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | 43 min agoDividend
Analysts recommendations
Institutional Ownership
SCPX Latest News
NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Scorpius Holdings, Inc. (the “Company”) — ticker symbol SCPX — from NYSE American. Trading in the Company's common stock will be suspended immediately. NYSE Regulation has determined that the Company is no longer suitable for listing pursuant to Section 1003(f)(v) of the NYSE American Company Guide.
Scorpius Holdings, Inc. announced the completion of its public offering of 60,000,000 common units at a price of $0.10 per unit, resulting in gross proceeds of $6,000,000. Each unit includes one share of common stock, a common warrant, and a pre-funded warrant to purchase one share of common stock. The warrants have an exercise price of $0.12 per share and can be exercised for five years. The underwriters have the option to purchase an additional 9,000,000 shares of common stock and/or warrants to cover any over-allotments.
What type of business is Scorpius Holdings?
Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies. It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
What sector is Scorpius Holdings in?
Scorpius Holdings is in the Healthcare sector
What industry is Scorpius Holdings in?
Scorpius Holdings is in the Biotechnology industry
What country is Scorpius Holdings from?
Scorpius Holdings is headquartered in United States
When did Scorpius Holdings go public?
Scorpius Holdings initial public offering (IPO) was on 24 July 2013
What is Scorpius Holdings website?
https://www.scorpiusbiologics.com
Is Scorpius Holdings in the S&P 500?
No, Scorpius Holdings is not included in the S&P 500 index
Is Scorpius Holdings in the NASDAQ 100?
No, Scorpius Holdings is not included in the NASDAQ 100 index
Is Scorpius Holdings in the Dow Jones?
No, Scorpius Holdings is not included in the Dow Jones index
When does Scorpius Holdings report earnings?
The next expected earnings date for Scorpius Holdings is 14 August 2024